Assessment of Postvaccine Immunity against Streptococcus pneumoniae in Patients with Asplenia, including an Analysis of Its Impact on Bacterial Flora of the Upper Respiratory Tract and Incidence of Infections

Abstract EN

S.

pneumoniae is a microorganism that may cause a serious threat in postsplenectomy patients due to a potentially invasive course of infection.

In order to assess a protective activity after vaccination with the 23-valent vaccine, we made an analysis of the level of antibodies in patients with asplenia compared to a control group of healthy donors.

Additionally, colonization by potentially pathogenic microorganisms of the upper respiratory tract was analyzed to determine the carrier state by strains with vaccine serotype.

No such strains were found in the research, yet three non-vaccine-serotype strains were found.

Colonization of the upper respiratory tract by potentially pathogenic microorganisms may be connected with increased susceptibility observed and incidence of infections in patients with asplenia.

However, colonization by S.

pneumoniae may not have an effect on the level of specific antibodies with the 23-valent vaccine against S.

pneumoniae (PPV23) in postsplenectomy patients and healthy people.

The response to vaccination against S.

pneumoniae showed a lower level of specific antibodies in patients with splenectomy performed more than 2 years before the test than in patients with a recently removed spleen, i.e., from 1 month to 2 years before the test.

Vaccination against pneumococci also has positive effects on incidence of other etiology infections, which is of high significance in the prophylaxis of infectious diseases in this group of patients.